Rothschild Investment LLC’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68K Buy
551
+538
+4,138% +$1.61K ﹤0.01% 2828
2026
Q1
$40 Buy
13
+12
+1,200% +$51 ﹤0.01% 3486
2025
Q4
$4 Buy
+1
New +$4 ﹤0.01% 3404
2025
Q3
Sell
-195
Closed -$755 3141
2025
Q2
$755 Buy
195
+30
+18% +$162 ﹤0.01% 2597
2025
Q1
$825 Buy
165
+30
+22% +$190 ﹤0.01% 2439
2024
Q4
$973 Buy
135
+70
+108% +$535 ﹤0.01% 2231
2024
Q3
$399 Buy
65
+45
+225% +$305 ﹤0.01% 2533
2024
Q2
$133 Buy
+20
New +$148 ﹤0.01% 2618

Other funds holding ALT

Rothschild Investment LLC's ALT Position: Q2 2026 in Review

Rothschild Investment LLC increased its Altimmune (ALT) stake by 4,138% in Q2 2026, buying an estimated $1.61K and bringing the position to 551 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

Rothschild Investment LLC first reported a position in ALT in Q2 2024 and has held it in 8 quarters since. 72 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Rothschild Investment LLC held 551 shares of Altimmune worth $1.68K as of Q2 2026.
  • Rothschild Investment LLC bought 538 Altimmune shares in Q2 2026, an estimated $1.61K.
  • Altimmune made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2828 holding.
  • Rothschild Investment LLC first reported a position in Altimmune in Q2 2024 and has held it in 8 quarters since.
  • 72 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.